0CUM Strategic Partners A/s

Company announcement Orphazyme A/SNo. 34/2022 www.orphazyme.comCompany Registration No. 32266355

Copenhagen, Denmark, September 19, 2022 – Orphazyme A/S (ORPHA.CO) (the “Company”) announces an update to the Company’s financial calendar in regard to the publication of the Company’s Interim Report First Half 2022. The Interim Report First Half 2022 will be published on September 26, 2022, previously September 20, 2022. Additional time is required to conclude the presentation of the financial statements following the sale of substantially all Orphazyme’s assets and business activities to KemPharm Denmark A/S, a wholly owned subsidiary of KemPharm, Inc. (KMPH: NASDAQ, NY) which completed during the reporting period.

Interim Report First Half 2022September 26, 2022

For additional information, please contact

Orphazyme A/S

Anders Vadsholt, Chief Executive Officer and Chief Financial Officer +45 28 98 90 55

Attachment

• Updated Financial Calendar for 2022 (H1 update)

Strategic Partners A/s (LSE:0CUM)
Gráfico Histórico do Ativo
De Dez 2024 até Jan 2025

Strategic Partners A/s (LSE:0CUM)
Gráfico Histórico do Ativo
De Jan 2024 até Jan 2025